Although both GSTM2-overexpressing mice and control mice showed good recovery of hepatic steatosis at 2 weeks, GSTM2-overexpressing mice showed lower hepatic fat content at 1 week (Fig. 2d). Here, GSTM2 is linked to fatty liver disease.